Background Faecal microbiota transplantation (FMT) is effective for recurrent Clostridioides
difficile infection (CDI), but inconsistent effect rates and uncertain evidence levels have …

Background Fecal microbiota transplantation (FMT) is highly effective for treating recurrent
Clostridium difficile infection (CDI) in observational studies (> 90%), but cure rates in clinical …

Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been
increasing globally in recent years, particularly as a result of randomised studies in which it …

Clostridioides difficile infection occurs when the bacterium produces toxin that causes
diarrhea and inflammation of the colon. These guidelines indicate the preferred approach to …

Background Protocols for treating recurrent Clostridium difficile infection (rCDI) through
faecal microbiota transplantation (FMT) are still not standardised. Our aim was to evaluate …

There have been a number of advances in probiotics and our understanding of their role in
prevention of CDI, but a number of important safety and efficacy questions remain. An …

Background Clostridium difficile is the leading cause of antibiotic-associated diarrhoea, both
in healthcare facilities and in the community. The recurrence rate of C. difficile infection (CDI) …

Objectives Although systematic evaluation has confirmed the efficacy of fresh fecal
microbiota transplantation (FMT) for treatment of recurrent and/or refractory and/or relapse …

Clostridioides difficile (formerly Clostridium) is a major cause of healthcare associated
diarrhea, and is increasingly present in the community. Historically, C difficile infection was …